This is a Validated Antibody Database (VAD) review about dog MAP2K5, based on 5 published articles (read how Labome selects the articles), using MAP2K5 antibody in all methods. It is aimed to help Labome visitors find the most suited MAP2K5 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MAP2K5 synonym: dual specificity mitogen-activated protein kinase kinase 5

Santa Cruz Biotechnology
mouse monoclonal (21)
  • western blot; human; 1:500; loading ...; fig 4b
Santa Cruz Biotechnology MAP2K5 antibody (SantaCruz, sc-135986) was used in western blot on human samples at 1:500 (fig 4b). Oncol Lett (2017) ncbi
mouse monoclonal (21)
  • western blot; human; fig 2 a',' b
In order to assess the contribution of MEK5/ERK5 signaling in the sensitivity of colon cancer cells to 5-fluorouracil, Santa Cruz Biotechnology MAP2K5 antibody (Santa Cruz Biotechnology, sc-135986) was used in western blot on human samples (fig 2 a',' b). Oncotarget (2016) ncbi
mouse monoclonal (21)
  • western blot; human; fig 1
Santa Cruz Biotechnology MAP2K5 antibody (Santa Cruz, sc-135986) was used in western blot on human samples (fig 1). Cell Death Dis (2015) ncbi
BD Biosciences
mouse monoclonal (21/MEK5)
  • western blot; mouse; fig 8b
BD Biosciences MAP2K5 antibody (BD biosciences, 610957) was used in western blot on mouse samples (fig 8b). EMBO Mol Med (2016) ncbi
mouse monoclonal (21/MEK5)
  • western blot; human; fig 1
BD Biosciences MAP2K5 antibody (BD Biosciences, 610956) was used in western blot on human samples (fig 1). EMBO J (2014) ncbi
Articles Reviewed
  1. Yang W, Wang X, Yuan H, Liu Z, Gao S, Peng L. Exploring the mechanism of WWOX growth inhibitory effects on oral squamous cell carcinoma. Oncol Lett. 2017;13:3198-3204 pubmed publisher
  2. Pereira D, Simões A, Gomes S, Castro R, Carvalho T, Rodrigues C, et al. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism. Oncotarget. 2016;7:34322-40 pubmed publisher
  3. Cuttano R, Rudini N, Bravi L, Corada M, Giampietro C, Papa E, et al. KLF4 is a key determinant in the development and progression of cerebral cavernous malformations. EMBO Mol Med. 2016;8:6-24 pubmed publisher
  4. Simões A, Pereira D, Gomes S, Brito H, Carvalho T, French A, et al. Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation. Cell Death Dis. 2015;6:e1718 pubmed publisher
  5. Takeda A, Oberoi Khanuja T, Glatz G, Schulenburg K, Scholz R, Carpy A, et al. Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1. EMBO J. 2014;33:1784-801 pubmed publisher